ABCL
Price
$5.31
Change
-$0.36 (-6.35%)
Updated
Jul 24 closing price
Capitalization
1.62B
11 days until earnings call
Intraday BUY SELL Signals
PROK
Price
$1.50
Change
-$0.02 (-1.32%)
Updated
Jul 24 closing price
Capitalization
307.8M
12 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs PROK

ABCL vs PROK Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABCL vs. PROK commentary
Jul 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a StrongBuy and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2026
Stock price -- (ABCL: $5.31 vs. PROK: $1.50)
Brand notoriety: ABCL and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 43% vs. PROK: 98%
Market capitalization -- ABCL: $1.62B vs. PROK: $307.8M
ABCL [@Biotechnology] is valued at $1.62B. PROK’s [@Biotechnology] market capitalization is $307.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, ABCL is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while PROK’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 6 bearish.
  • PROK’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, both ABCL and PROK are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -17.87% price change this week, while PROK (@Biotechnology) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.78%. For the same industry, the average monthly price growth was -3.76%, and the average quarterly price growth was +1901.89%.

Reported Earning Dates

ABCL is expected to report earnings on Aug 05, 2026.

PROK is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.62B) has a higher market cap than PROK($308M). ABCL YTD gains are higher at: 55.263 vs. PROK (-33.036). PROK has higher annual earnings (EBITDA): -149.81M vs. ABCL (-167.02M). ABCL has more cash in the bank: 505M vs. PROK (225M). PROK has less debt than ABCL: PROK (3.78M) vs ABCL (140M). ABCL has higher revenues than PROK: ABCL (79.2M) vs PROK (889K).
ABCLPROKABCL / PROK
Capitalization1.62B308M526%
EBITDA-167.02M-149.81M111%
Gain YTD55.263-33.036-167%
P/E RatioN/AN/A-
Revenue79.2M889K8,909%
Total Cash505M225M224%
Total Debt140M3.78M3,701%
TECHNICAL ANALYSIS
Technical Analysis
ABCLPROK
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
72%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 30 days ago
80%
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
PROK
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DVYE33.790.08
+0.24%
iShares Emerging Markets Dividend ETF
RNRG34.92N/A
N/A
Global X Renewable Energy Producers ETF
SPRX51.05N/A
N/A
Spear Alpha ETF
TSEL29.12N/A
N/A
Touchstone Sands Capital US Sel Gr ETF
SHPU12.74N/A
N/A
Direxion Daily SHOP Bull 2X ETF

PROK and

Correlation & Price change

A.I.dvisor indicates that over the last year, PROK has been loosely correlated with RXRX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if PROK jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PROK
1D Price
Change %
PROK100%
-1.32%
RXRX - PROK
52%
Loosely correlated
-1.66%
SANA - PROK
49%
Loosely correlated
-0.93%
ABCL - PROK
45%
Loosely correlated
-6.35%
BEAM - PROK
43%
Loosely correlated
-3.13%
CRBU - PROK
43%
Loosely correlated
-3.68%
More